Residues at the Subunit Interfaces of the Nicotinic Acetylcholine Receptor That Contribute to α-Conotoxin M1 Binding
- Naoya Sugiyama1,1,
- Pascale Marchot2,1,
- Chiaki Kawanishi1,1,
- Hitoshi Osaka1,
- Brian Molles1,
- Steven M. Sine2 and
- Palmer Taylor1
- 1Department of Pharmacology, University of California, San Diego, La Jolla, California 92093 (N.S., P.M., C.K., H.O., B.M., P.T.) and2Department of Physiology and Biophysics, Mayo Clinic and Foundation, Rochester, Minnesota 55455 (S.M.S.)
Abstract
The two binding sites in the pentameric nicotinic acetylcholine receptor of subunit composition α2βγδ are formed by nonequivalent α-γ and α-δ subunit interfaces, which produce site selectivity in the binding of agonists and antagonists. We show by sedimentation analysis that 125I-α-conotoxin M1 binds with high affinity to the α-δ subunit dimers, but not to α-γ dimers, nor to α, γ, and δ monomers, a finding consistent with α-conotoxin M1 selectivity for the αδ interface in the intact receptor measured by competition against α-bungarotoxin binding. We also extend previous identification of α-conotoxin M1 determinants in the γ and δ subunits to the α subunit interface by mutagenesis of conserved residues in the α subunit. Most mutations of the α subunit affect affinity similarly at the two sites, but Tyr93Phe, Val188Lys, Tyr190Thr, Tyr198Thr, and Asp152Asn affect affinity in a site-selective manner. Mutant cycle analysis reveals only weak or no interactions between mutant α and non-α subunits, indicating that side chains of the α subunit do not interact with those of the γ or δ subunits in stabilizing α-conotoxin M1. The overall findings suggest different binding configurations of α-conotoxin M1 at the α-δ and α-γ binding interfaces.
Footnotes
-
Send reprint requests to: Dr. Palmer Taylor, Dept. of Pharmacology, Basic Science Bldg./0636, University of California-San Diego, 9500 Gilman Dr., La Jolla, CA 93093-0636.
-
↵1 Current affiliation: Yokohama City University, Yokohama, Japan.
-
↵2 Current affiliation: Centre National de la Recherche Scientifique UAR 6560, Institut Federatif de Recherche Jean Roche, Laboratoire de Biochemie, F-13916 Marseille Cedex 20, France.
-
This work was supported by United States Public Health Service Grants GM18360 (P.T.) and NS31744 (S.M.S.).
- Abbreviations:
- HEK
- human embryonic kidney
-
- Received December 1, 1997.
- Accepted January 12, 1998.
- The American Society for Pharmacology and Experimental Therapeutics



